poliovirus vaccine live oral trivalent (Discontinued)Brand and Other Names:OPV, Orimune, more...Sabin, TOPV

 
 
 

Dosing & Uses

AdultPediatric

Poliovirus Prevention

0.5 mL PO; 2 doses > 6 weeks apart or <8 weeks apart followed by third dose 6-12 months later

Additional Information

Up-to-date vaccination schedules available at www.cdc.gov/nip/publications

Other Indications & Uses

Now recommended only during polio outbreaks, travel to endemic areas, or if pt refuses injectable form

Poliovirus Prevention

Infants: 0.5 mL; at 2, 4, and 15-18 months old; fourth dose given when child begins school

Childresn and adolescents: 0.5 mL PO; 2 doses > 6 weeks apart or <8 weeks apart followed by third dose 6-12 months later

Next

Interactions

Interaction Checker

poliovirus vaccine live oral trivalent and

No Results

     
     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            Sort by :  
             activity indicator 
            Previous
            Next

            Adverse Effects

            Suspected adverse events after administration of any vaccine may be reported to Vaccine Adverse Events Reporting System (VAERS), 1-800-822-7967

            Postmarketing Reports

            Headache

            Vomiting

            Diarrhea

            Fever

            Vaccine-associated paralysis in 1 of 2.6 million doses

            Allergy to neomycin or streptomycin

            Anaphylaxis

            Guillain-Barre syndrome

            Previous
            Next

            Warnings

            Contraindications

            Immunocompromised pt. or household member

            History of anaphylaxis

            Cautions

            Risk of vaccine-associated paralysis in vaccinee or household member or other contactee

            Use IPV for travel if <4 wk until departure

            HIV+

            Previous
            Next

            Pregnancy & Lactation

            Pregnancy Category: B

            Lactation: not known if excreted in breast milk

            Pregnancy Categories

            A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

            B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

            C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

            D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

            X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

            NA:Information not available.

            more...
            Previous
            Next

            Pharmacology

            These products convey active immunity via stimulation of production of endogenously produced antibodies

            The onset of protection from disease is relatively slow, but duration is long lasting (years)

            Duration: Unknown

            Mechanism of Action

            Induction of active immunization against poliovirus type 1 by live attenuated poliomyelitis virus Sabin strain type 1

            Attenuated, live virus multiplies in intestine & spreads to others in household to immunize

            Previous
            Next

            Images

            Previous
            Next
             
             
             
            All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.